Company intelligence / Profile preview

SEAS Biotech

Ownership: Private
Development stage: Commercial

Overview

SEAS Biotech Private Limited is an Indian private company established in 2021, focused on the manufacture of grain-based fuel-grade ethanol and distillers dried grains with solubles (DDGS), a protein-rich byproduct used as cattle feed. The company has set up a greenfield project for first-generation ethanol production from rice and maize with a capacity of 100 KLPD. It also operates a 3 MW co-generation power plant. There are no clinical results or drug development activities associated with this entity.

Industry: Non-Drug Biotech

Partnerships

Long-term off-take agreement with Oil Marketing Companies (OMCs)

Beyond the preview

Go deeper on SEAS Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SEAS Biotech.

Explore the full profile